Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms
about
The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution.Pharmacovigilance in oncology: evaluation of current practice and future perspectives.CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma.A rare case of osteonecrosis of the jaw related to imatinib[Treatment side effects and follow-up of malignant melanoma].Interstitial Lung Disease Induced by Pazopanib TreatmentPharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma.Immune-related tumor response assessment criteria: a comprehensive review.Lung, CNS and musculo-skeletal targeted therapy-induced toxicity: imaging features.
P2860
Q35025984-44558EE9-B1F6-401D-860C-1131780508E6Q35183601-FB0C90D9-7BCE-49BC-9ED3-D417D981D32AQ35292720-3EEAB8AF-DCBE-45F4-AABD-9ACBD03DF035Q36360226-087180F2-D484-438D-AE76-4CF8F17C86C4Q41516358-0326ED0B-312F-490D-BBA6-20994EC002DEQ42320949-FD51DE69-85E6-479A-BA6F-6CDE9EAF1359Q47123004-04F3BA93-FDE1-4C43-A3DF-AAB0ABE7C451Q49668388-F8F918DF-9369-4324-B960-D3D5E33A7A2DQ55380706-8F5886AC-0AE5-49AF-A654-BD190CBAC5D1
P2860
Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Complications of targeted drug ...... manifestations and mechanisms
@en
type
label
Complications of targeted drug ...... manifestations and mechanisms
@en
prefLabel
Complications of targeted drug ...... manifestations and mechanisms
@en
P2093
P2860
P356
P1476
Complications of targeted drug ...... manifestations and mechanisms
@en
P2093
Emily Chan
Jeffrey A Sosman
Leora Horn
Richard G Abramson
Vandana G Abramson
Vicki L Keedy
P2860
P304
P356
10.2214/AJR.12.9049
P407
P50
P577
2013-03-01T00:00:00Z